A review on airway biomarkers: exposure, effect and susceptibility

References

• Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J RespirCrit Care Med 2011;163:1256-76
   Google Scholar
• Trappenburg JC, van Deventer AC, Troosters T, et al. The impact of using different symptom-based exacerbation algorithms in patients with COPD. Eur Respir J 2011;37:1260-8
   Google Scholar
• Trappenburg JC, Touwen I, de Weert-van Oene GH, et al. Detecting exacerbations using the Clinical COPD Questionnaire. Health Qual Life Outcomes 2010;16(8):102
   Google Scholar
• Limb SL, Brown KC, Wood RA, et al. Irreversible lung function deficits in young adults with a history of childhood asthma. J Allergy ClinImmunol 2005;116:1213-39
   PubMed Web of Science ®Google Scholar
• Baines KJ, Pavord ID, Gibson PG. The role of biomarkers in the management of airways disease. Int J Tuberc Lung Dis 2014;18:1264-8
   PubMed Web of Science ®Google Scholar
• Capelli A, Di Stefano A, Gnemmi I, et al. Increased MCP-1 and MIP-1beta in bronchoalveolar lavage fluid of chronic bronchitics. EurRespir J 1999;14:160-5
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Capelli A, Lusuardi M, et al. Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease. Clin Exp Allergy 2001;31:893-902
   PubMed Web of Science ®Google Scholar
• Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008;31:416-69
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95
   PubMed Web of Science ®Google Scholar
• Mutti A. Biological monitoring as a means to assess exposure and to predict adverse effects of chemical pollutants: an overview of current activities in key Italian laboratories. Med Lav 2012;103:413-16
   Google Scholar
• Corradi M, Gergelova P, Mutti A. Use of exhaled breath condensate to investigate occupational lung diseases. Curr Opin Allergy Clin Immunol 2010;10:93-8
   PubMed Web of Science ®Google Scholar
• Fireman E. Induced sputum and occupational diseases other than asthma. Curr Opin Allergy Clin Immunol 2009;9:93-6
   PubMed Web of Science ®Google Scholar
• Churg A. The diagnosis of asbestosis. Hum Pathol 1989;20:97-9
   PubMed Web of Science ®Google Scholar
• Vathesatogkit P, Harkin TJ, Addrizzo-Harris DJ, et al. Clinical correlation of asbestos bodies in BAL fluid. Chest 2004;126:966-71
   PubMedGoogle Scholar
• Bernstein D, Castranova V, Donaldson K, et al. Testing of fibrous particles: short-term assays and strategies. Inhal Toxicol 2005;17:497-537
   PubMed Web of Science ®Google Scholar
• Billon-Galland MA. [Exposition markers: mineralogical analysis in the sputum and the bronchoalveolar lavage–asbestos bodies–uncoated fibres]. Rev Mal Respir 2012;29:521-8
   Google Scholar
• Teschler H, Thompson AB, Dollenkamp R, et al. Relevance of asbestos bodies in sputum. Eur Respir J 1996;9:680-6
   PubMed Web of Science ®Google Scholar
• Karjalainen A, Piipari R, Mäntylä T, et al. Asbestos bodies in bronchoalveolar lavage in relation to asbestos bodies and asbestos fibres in lung parenchyma. Eur Respir J 1996;9:1000-5
   Google Scholar
• Karjalainen A, Nurminen M, Vanhala E, et al. Pulmonary asbestos bodies and asbestos fibers as indicators of exposure. Scand J Work Environ Health 1996;22:34-8
   Google Scholar
• De Vuyst P, Dumortier P, Léophonte P, et al. Mineralogical analysis of bronchoalveolar lavage in talc pneumoconiosis. Eur J Respir Dis 1987;70:150-6
   PubMedGoogle Scholar
• Honma K, Abraham JL, Chiyotani K. Proposed criteria for mixed-dust pneumoconiosis: definition, descriptions, and guidelines for pathologic diagnosis and clinical correlation. Hum Pathol 2004;35:1515-23
   PubMed Web of Science ®Google Scholar
• Watkins JP, Ellis ED, Girardi DJ, et al. Illness absences among beryllium sensitized workers. Am J Public Health 2014;104:e165-9
   Google Scholar
• Fireman E, Mazor O, Kramer M, et al. Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel. Occup Environ Med 2010;67:631-5
   PubMed Web of Science ®Google Scholar
• Churg A, Brauer M. Ambient atmospheric particles in the airways of human lungs. Ultrastruct Pathol 2000;24:353-61
   PubMed Web of Science ®Google Scholar
• Fireman EM, Lerman Y, Ganor E, et al. Induced sputum assessment in New York City firefighters exposed to World Trade Center dust. Environ Health Perspect 2004;112:1564-9
   PubMed Web of Science ®Google Scholar
• Fireman E, Bliznuk D, Schwarz Y, et al. Biological monitoring of particulate matter accumulated in the lungs of urban asthmatic children in the Tel-Aviv area. Int Arch Occup Environ Health 2014. [Epub ahead of print]
   Google Scholar
• Goldoni M, Caglieri A, De Palma G, et al. Development and set-up of a portable device to monitor airway exhalation and deposition of particulate matter. Biomarkers 2009;14:326-39
   Web of Science ®Google Scholar
• Invernizzi G, Boffi R, Ruprecht AA, et al. Real-time measurement of particulate matter deposition in the lung. Biomarkers 2006;11:221-32
   PubMed Web of Science ®Google Scholar
• Londahl J, Swietlicki E, Rissler J, et al. Experimental determination of the respiratory tract deposition of diesel combustion particles in patients with chronic obstructive pulmonary disease. Part Fibre Toxicol 2012;28:9-30
   Google Scholar
• Murgia N, Muzi G, Dell’ Omo M, et al. Induced sputum, exhaled breath condensate and nasal lavage fluid in electroplating workers exposed to chromium. Int J Immunopathol Pharmacol 2006;19:67-71
   Google Scholar
• Goldoni M, Catalani S, De Palma G, et al. Exhaled breath condensate as a suitable matrix to assess lung dose and effects in workers exposed to cobalt and tungsten. Environ Health Perspect 2004;112:1293-8
   PubMed Web of Science ®Google Scholar
• Goldoni M, Caglieri A, De Palma G, et al. Chromium in exhaled breath condensate (EBC), erythrocytes, plasma and urine in the biomonitoring of chrome-plating workers exposed to soluble Cr(VI). J Environ Monit 2010;12:442-7
   Google Scholar
• Goldoni M, Caglieri A, Corradi M, et al. Chromium in exhaled breath condensate and pulmonary tissue of non-small cell lung cancer patients. Int Arch Occup Environ Health 2008;81:487-93
   Google Scholar
• Hulo S, Charot-Kornobis N, Howsam M, et al. Manganese in exhaled breath condensate: a new marker of exposure to welding fumes. Toxicol Lett 2014;226:63-9
   Google Scholar
• Felix PM, Almeida SM, Franco C, et al. The suitability of EBC-Pb as a new biomarker to assess occupational exposure to lead. Int J Environ Health Res 2015;25(1):67-80
   PubMed Web of Science ®Google Scholar
• Amorim LC, de L Cardeal Z. Breath air analysis and its use as a biomarker in biological monitoring of occupational and environmental exposure to chemical agents. J Chromatogr B Analyt Technol Biomed Life Sci 2007;853:1-9
   PubMed Web of Science ®Google Scholar
• Egeghy PP, Nylander-French L, Gwin KK, et al. Self-collected breath sampling for monitoring low-level benzene exposures among automobile mechanics. Ann Occup Hyg 2002;46:489-500
   PubMed Web of Science ®Google Scholar
• Sweet ND, Burroughs GE, Ewers L, et al. A field method for near real-time analysis of perchloroethylene in end-exhaled breath. J Occup Environ Hyg 2004;1:515-20
   PubMed Web of Science ®Google Scholar
• Thompson LM, Clark M, Cadman B, et al. Exposures to high levels of carbon monoxide from wood-fired temazcal (steam bath) use in highland Guatemala. Int J Occup Environ Health 2011;17:103-12
   PubMed Web of Science ®Google Scholar
• Miranda AI, Martins V, Cascao P, et al. Wildland smoke exposure values and exhaled breath indicators in firefighters. J Toxicol Environ Health A 2012;75:831-43
   PubMed Web of Science ®Google Scholar
• Pope D, Diaz E, Smith-Sivertsen T, et al. Associations of respiratory symptoms and lung function with measured carbon monoxide concentrations among nonsmoking women exposed to household air pollution: The RESPIRE trial, Guatemala. Environ Health Perspect 2014. [Epub ahead of print]
   Google Scholar
• Ryter SW. Special issue on carbon monoxide and exhaled biomarkers in human disease. J Breath Res 2010;4:040201
   Google Scholar
• Gajdocsy R, Horvath I. Exhaled carbon monoxide in airway diseases: from research findings to clinical relevance. J Breath Res 2010;4:047102
   Google Scholar
• Suk WA, Collman G, Damstra T. Human biomonitoring: research goals and needs. Environ Health Perspect 1996;104:479-83
   PubMedGoogle Scholar
• Mutti A, Corradi M, Goldoni M, et al. Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. Chest 2006;129:1288-97
   PubMed Web of Science ®Google Scholar
• Dharuri H, Demirkan A, van Klinken JB, et al. Genetics of the human metabolome, what is next? Biochim Biophys Acta 2014;1842:1923-31
   Google Scholar
• Carraro S, Rezzi S, Reniero F, et al. Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2007;175:986-90
   PubMed Web of Science ®Google Scholar
• Carraro S, Giordano G, Reniero F, et al. Asthma severity in childhood and metabolomic profiling of breath condensate. Allergy 2013;68:110-17
   PubMed Web of Science ®Google Scholar
• Bennett DA, Waters MD. Applying biomarker research. Environ Health Perspect 2000;108:907-10
   PubMedGoogle Scholar
• Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:1715-21
   PubMed Web of Science ®Google Scholar
• Efthimiadis A, Spanevello A, Hamid Q, et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl 2002;37:19s-23s
   PubMedGoogle Scholar
• Wagener AH, Yick CY, Brinkman P, et al. Toward composite molecular signatures in the phenotyping of asthma. Ann Am Thorac Soc 2013;10:S197-205
   PubMedGoogle Scholar
• Leung TF, Ko FW, Wong GW. Recent advances in asthma biomarker research. Ther Adv Respir Dis 2013;7:297-308
   PubMed Web of Science ®Google Scholar
• Schleich FN, Chevremont A, Paulus V, et al. Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. Eur Respir J 2014;44:97-108
   PubMed Web of Science ®Google Scholar
• Pavord ID, Gibson PG. Inflammometry: the current state of play. Thorax 2012;67:191-2
   Google Scholar
• Petsky HL, Cates CJ, Lasserson TJ, et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2012;67:199-208
   PubMed Web of Science ®Google Scholar
• Kips JC, O’Connor BJ, Inman MD, et al. A long-term study of the anti-inflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma. Am J Respir Crit Care Med 2000;161:996-1001
   PubMed Web of Science ®Google Scholar
• Turner MO, Johnston PR, Pizzichini E, et al. Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial. Can Respir J 1998;5:261-8
   PubMedGoogle Scholar
• Pizzichini E, Leff JA, Reiss TF, et al. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J 1999;14:12-18
   PubMed Web of Science ®Google Scholar
• Louis R, Bettiol J, Cataldo D, et al. Effect of a 4-week treatment with theophylline on sputum eosinophilia and sputum eosinophil chemotactic activity in steroid-naive asthmatics. Clin Exp Allergy 2000;30:1151-60
   Google Scholar
• Brightling CE, Bleecker ER, Panettieri RAJr, et al. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. Lancet Respir Med 2014;2(11):891-901
   PubMed Web of Science ®Google Scholar
• Laviolette M, Gossage DL, Gauvreau G, et al. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. J Allergy Clin Immunol 2013;132:1086-96
   PubMed Web of Science ®Google Scholar
• Stanescu D, Sanna A, Veriter C, et al. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996;51:267-71
   PubMed Web of Science ®Google Scholar
• Singh D, Edwards L, Tal-Singer R, et al. Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study. Respir Res 2010;11:77
   PubMed Web of Science ®Google Scholar
• Sobiecka M, Kus J, Demkow U, et al. Induced sputum in patients with interstitial lung disease: a non-invasive surrogate for certain parameters in bronchoalveolar lavage fluid. J Physiol Pharmacol 2008;59:645-57
   Google Scholar
• Mroz RM, Chyczewska E, Korniluk M, et al. Comparison of cellular composition of induced sputum, bronchial washings and bronchoalveolar lavage fluid in sarcoidosis, hypersensitivity pneumonitis and COPD. Pneumonol Alergol Pol 2002;70:468-77
   Google Scholar
• Fireman E, Boikaner T, Priel IE. Combined CD4/CD8 ratio in induced sputum and pulmonary function testing for non-invasive identification of sarcoidosis. Transl Res 2006;148:87-95
   Google Scholar
• Fireman Z, Osipov A, Kivity S, et al. The use of induced sputum in the assessment of pul- monary involvement in Crohn’s disease. Am J Gastroenterol 2000;95:730-4
   PubMed Web of Science ®Google Scholar
• Neudorfer M, Leibovitch I, Onn A, et al. Induced sputum for identifying sarcoidosis in patients with uveitis. Ophthalmology 2002;109:858-61
   Google Scholar
• Hill A, Bayley D, Stockley R. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. AmJ Respir Crit Care Med 1999;160:893-8
   PubMed Web of Science ®Google Scholar
• Barnes P, Chowdhury B, Kharitonov S, et al. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:6-14
   PubMed Web of Science ®Google Scholar
• Hemelaers L, Henket M, Sele J, et al. Cysteinyl leukotrienes contribute to sputum eosinophil chemotactic activity in asthmatics. Allergy 2006; 61:136-9
   Google Scholar
• Kodric M, Shah AN, Fabbri LM, et al. An investigation of airway acidification in asthma using induced sputum: a study of feasibility and correlation. Am J Respir Crit Care Med 2007;175:905-10
   PubMed Web of Science ®Google Scholar
• Sugiura H, Komaki Y. KoaraiA, et al. Nitrative stress in refractory asthma. J Allergy Clin Immunol 2008;121:355-60
   PubMed Web of Science ®Google Scholar
• Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J RespirCrit Care Med 2011;184:602-15
   PubMed Web of Science ®Google Scholar
• Petsky HL, Cates CJ, Li A, et al. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2009;7(4):CD006340
   Google Scholar
• Corradi M, Montuschi P, Donnelly LE, et al. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med 2001;163:854-8
   PubMed Web of Science ®Google Scholar
• Corradi M, Majori M, Cacciani GC. Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease. Thorax 1999;54:572-5
   PubMed Web of Science ®Google Scholar
• Papi A, Romagnoli M, Baraldo S, et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:1773-7
   PubMed Web of Science ®Google Scholar
• Brussino L, Culla B, Bucca C, et al. Inflammatory cytokines and VEGF measured in exhaled breath condensate are correlated with tumor mass in non-small cell lung cancer. J Breath Res 2014;8:027110
   Google Scholar
• Karakoc GB, Yukselen A, Yilmaz M. Exhaled breath condensate MMP-9 level and its relationship wƒ±th asthma severity and interleukin-4/10 levels in children. Ann Allergy Asthma Immunol 2012;108:300-4
   Web of Science ®Google Scholar
• Robroeks CM, Rijkers GT, Jobsis Q, et al. Increased cytokines, chemokines and soluble adhesion molecules in exhaled breath condensate of asthmatic children. Clin Exp Allergy 2010;40:77-84
   PubMed Web of Science ®Google Scholar
• Horvath I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005;26:523-48
   PubMed Web of Science ®Google Scholar
• Corradi M, Folesani G, Andreoli R, et al. Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am J Resp Crit Care Med 2003;167:395-9
   PubMed Web of Science ®Google Scholar
• Lee JS, Shin JH, Hwang JH, et al. Malondialdehyde and 3-nitrotyrosine in exhaled breath condensate in retired elderly coal miners with chronic obstructive pulmonary disease. Saf Health Work 2014;5:91-6
   Google Scholar
• Sauvain JJ, Sánchez Sandoval Hohl M, Wild P, et al. Exhaled breath condensate as a matrix for combustion-based nanoparticle exposure and health effect evaluation. J Aerosol Med Pulm Drug Deliv 2014;27(6):449-58
   Google Scholar
• MacNee W, Rennard SI, Hunt JF, et al. Evaluation of exhaled breath condensate pH as a biomarker for COPD. Respir Med 2011;105:1037-45
   Google Scholar
• Hunt JF, Fang K, Malik R, et al. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000;161:694-9
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AM, Holbrook JT, Wei CY, et al. Exhaled breath condensate pH does not discriminate asymptomatic gastroesophageal reflux or the response to lansoprazole treatment in children with poorly controlled asthma. J Allergy Clin ImmunolPract 2014;2:579-86
   Google Scholar
• Teng Y, Sun P, Zhang J, et al. Hydrogen peroxide in exhaled breath condensate in patients with asthma: a promising biomarker? Chest 2011;140:108-16
   PubMed Web of Science ®Google Scholar
• Murata K, Fujimoto K, Kitaguchi Y, et al. Hydrogen peroxide content and pH of expired breath condensate from patients with asthma and COPD. COPD 2014;11:81-7
   Google Scholar
• Kazani S, Planaguma A, Ono E, et al. Exhaled breath condensate eicosanoid levels associate with asthma and its severity. J Allergy Clin Immunol 2013;132:547-53
   PubMed Web of Science ®Google Scholar
• Loukides S, Kontogianni K, Hillas G, et al. Exhaled breath condensate in asthma: from bench to bedside. Curr Med Chem 2011;18:1432-43
   PubMed Web of Science ®Google Scholar
• Esther CRJr, Boysen G, Olsen BM, et al. Mass spectro- metric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis. Am J Physiol Lung Cell MolPhysiol 2009;296:L987-93
   Web of Science ®Google Scholar
• vanMastrigt E, de Jongste JC, Pijnenburg MW. The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children - clinical tools or scientific toys? Clin Exp Allergy 2014. [Epub ahead of print]
   Google Scholar
• Kralimarkova TZ, Popov TA. Exhaled breath temperature: broadening the horizons. Int J Tuberc Lung Dis 2014;18:250-1
   Google Scholar
• de Lacy Costello B, Amann A, Al-Kateb H, et al. A review of the volatiles from the healthy human body. J Breath Res 2014;8:014001
   PubMed Web of Science ®Google Scholar
• Phillips M, Gleeson K, Hughes JM, et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 1999;353:1930-3
   PubMed Web of Science ®Google Scholar
• Amann A, Corradi M, Mazzone P, et al. Lung cancer biomarkers in exhaled breath. Expert Rev MolDiagn 2011;11:207-17
   PubMed Web of Science ®Google Scholar
• Bajtarevic A, Ager C, Pienz M, et al. Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer 2009;9:348
   PubMed Web of Science ®Google Scholar
• Di Natale C, Macagnano A, Martinelli E, et al. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens Bioelectron 2003;18:1209-18
   PubMed Web of Science ®Google Scholar
• Bos LD, Weda H, Wang Y, et al. Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome. Eur Respir J 2014;44:188-97
   Google Scholar
• Hubers AJ, Brinkman P, Boksem RJ, et al. Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis. J Clin Pathol 2014;67:707-11
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Torres A, Huerta A, et al. C-Reactive Protein at discharge, diabetes mellitus and ≥1 hospitalization during previous year predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease. COPD 2014. [Epub ahead of print]
   Google Scholar
• Coxson HO, Dirksen A, Edwards LD, et al. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. Lancet Respir Med 2013;1:129-36
   PubMed Web of Science ®Google Scholar
• Sin DD, Leung R, Gan WQ, et al. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm Med 2007;8:7-13
   Google Scholar
• Lomas DA, Silverman EK, Edwards LD, et al. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax 2008;63:1058-63
   PubMed Web of Science ®Google Scholar
• Luisetti M, Ma S, Iadarola P, et al. Desmosine as a biomarker of elastin degradation in COPD: current status and future directions. Eur Respir J 2008;32:1146-57
   PubMed Web of Science ®Google Scholar
• Lindberg CA, Engstrom G, de Verdier MG, et al. Total desmosines in plasma and urine correlate with lung function1. Eur Respir J 2012;39:839-45
   PubMed Web of Science ®Google Scholar
• Ma S, Lin YY, Tartell L, et al. The effect of tiotropium therapy on markers of elastin degradation in COPD. Respir Res 2009;10:12
   PubMed Web of Science ®Google Scholar
• Daham K, James A, Balgoma D, et al. Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma. J Allergy Clin Immunol 2014;134:306-13
   PubMed Web of Science ®Google Scholar
• Baek HS, Choi JH, Oh JW, et al. Leptin and urinary leukotriene E4 and prostaglandin F2 release after exercise challenge. Ann Allergy Asthma Immunol 2013;111:112-17
   Google Scholar
• Faner R, Tal-Singer R, Riley JH, et al. Lessons from ECLIPSE: a review of COPD biomarkers. Thorax 2014;69:666-72
   PubMed Web of Science ®Google Scholar